[Natural course and recommendation of therapy for HBV infection].
Yatsuhashi
Hiroshi
H
National Hospital Organization Nagasaki Medical Center, Clinical Research Center.
Nagaoka
Shinya
S
Abiru
Seigou
S
D000998:Antiviral Agents / Q000008:administration & dosage; D015415:Biomarkers; D002353:Carrier State; D004279:DNA, Viral / Q000032:analysis; D006147:Guanine / Q000008:administration & dosage / Q000031:analogs & derivatives; D006514:Hepatitis B Surface Antigens / Q000276:immunology; D006513:Hepatitis B e Antigens / Q000276:immunology; D006515:Hepatitis B virus / Q000235:genetics; D019694:Hepatitis B, Chronic / Q000188:drug therapy* / Q000276:immunology / Q000821:virology*; D006801:Humans; D019259:Lamivudine / Q000008:administration & dosage; D008103:Liver Cirrhosis / Q000209:etiology / Q000517:prevention & control; D008113:Liver Neoplasms / Q000209:etiology / Q000517:prevention & control; D012307:Risk Factors
D000998:Antiviral Agents; D015415:Biomarkers; D004279:DNA, Viral; D006514:Hepatitis B Surface Antigens; D006513:Hepatitis B e Antigens; D019259:Lamivudine; C413685:entecavir; D006147:Guanine